Loading chat...
OK SB717
Bill
Status
2/2/2015
Primary Sponsor
Rob Standridge
Click for details
AI Summary
-
Authorizes the Oklahoma Health Care Authority to take all necessary actions to maintain pharmacy reimbursement rates at current levels if the Centers for Medicare and Medicaid Services transitions to National Average Drug Acquisition Cost (NADAC) pricing methods.
-
Prohibits the Authority from either lowering or raising pharmacy reimbursement rates in response to a NADAC pricing transition.
-
Directs the Oklahoma Health Care Authority Board to promulgate rules to implement the provisions of this act.
-
Becomes effective November 1, 2015.
Legislative Description
Oklahoma Health Care Authority; authorizing certain actions under certain circumstances. Effective date.
Last Action
Second Reading referred to Health and Human Services Committee then to Appropriations Committee
2/3/2015